Patents by Inventor Andrea Thompson

Andrea Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soybean variety 5PFSR86
    Patent number: 11997976
    Abstract: A novel soybean variety, designated 5PFSR86 is provided. Also provided are the seeds of soybean variety 5PFSR86, cells from soybean variety 5PFSR86, plants of soybean 5PFSR86, and plant parts of soybean variety 5PFSR86. Methods provided include producing a soybean plant by crossing soybean variety 5PFSR86 with another soybean plant, methods for introgressing a transgenic trait, a mutant trait, and/or a native trait into soybean variety 5PFSR86, methods for producing other soybean varieties or plant parts derived from soybean variety 5PFSR86, and methods of characterizing soybean variety 5PFSR86. Soybean seed, cells, plants, germplasm, breeding lines, varieties, and plant parts produced by these methods and/or derived from soybean variety 5PFSR86 are further provided.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: June 4, 2024
    Assignee: PIONEER HI-BRED INTERNATIONAL, INC.
    Inventors: Andrea Beth Kalvig, Jeffrey A Thompson
  • PROCESS TO PRODUCE MONO-RHAMNOLIPIDS
    Publication number: 20240093257
    Abstract: The invention concerns a process to convert di-rhamnolipid to mono-rhamnolipid, using an ?-L-rhamnosidase enzyme which has a sequence identity of at least 70% with either SEQ ID. 1 or SEQ. ID 2.
    Type: Application
    Filed: April 25, 2022
    Publication date: March 21, 2024
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Natalia Eliza Iyke DOMERADZKA, Dietmar Andreas LANG, Neil James PARRY, Mark Lawrence THOMPSON
  • PROCESS TO PRODUCE MONO-RHAMNOLIPIDS
    Publication number: 20240084353
    Abstract: The invention concerns a process to convert di-rhamnolipid to mono-rhamnolipid comprising the following process steps: —(a) contact of a starting di-rhamnolipid material with an ?-L-rhamnosidase enzyme which is immobilised on a support; (b) separation of the produced mono-rhamnolipid from the reaction medium and/or side products; wherein the ?-L-rhamnosidase enzyme does not have ?-D-glucosidase activity.
    Type: Application
    Filed: April 25, 2022
    Publication date: March 14, 2024
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Natalia Eliza Iyke DOMERADZKA, Dietmar Andreas LANG, Neil James PARRY, Mark Lawrence THOMPSON
  • Injectable composition for inductive bone repair
    Patent number: 4863732
    Abstract: Aqueous suspensions of fibrillar atelopeptide collagen and osteogenic factor are effective injectable preparations for the repair of bone defects.
    Type: Grant
    Filed: December 16, 1987
    Date of Patent: September 5, 1989
    Assignee: Collagen Corporation
    Inventors: Ranga Nathan, Andrea Thompson, Saeid Seyedin